Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy
Clinical trial NCT00463203 · COMPLETED
Trial details
- NCT number
- NCT00463203
- Sponsor
- Rigshospitalet, Denmark
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-03-01
- Primary completion
- 2011-03-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.